MDL 926 Revised Settlement Program: Deficient Claims

Did you recently receive a Status letter from the Claims Administrator's Office, indicating that your Disease Claim had one or more Deficiencies?  We Can Help.

Althought the Revised Settlement Program (RSP) officially closed on December 15th 2010, we can still help you if you received a deficiency letter in 2011 from the MDL 926 Revised Settlement Claims Office after submitting a new disease claim or filed additional medical records in 2010.

As you may know, RSP Claimants only have one year from the date of the deficiency letter to cure any deficiencies. If you received a deficiency letter from the Claims Office in 2011 for your General Connective Tissue Symptoms (GCTS) Disease Claim, or Long Term Benefit Disease Claim for Scleroderma (SS), or Systemic Lupus Erythematosus (SLE) call our office today for a free, no obligation consultation about your potential claim.

Over the past 17 years, our law firm has successfully represented thousands of breast implant claimants in both the MDL 926 Revised Settlement Program and Dow Corning Settlement. We have a strong record of success curing a multitude of claim deficiencies, many requiring our office to file articulated appeals.

If you are a registered claimant in the MDL 926 Revised Settlement Program, and have the following:

• Already filed a Disease Claim prior to the 12/15/2010 deadline
• Received a deficiency notice
• Submitted additional supporting medical records prior to 12/15/2010
• Received a denial in 2011

You have the right to appeal the Claims Offices' ruling within 45 days of notification of your denial.

Call or Email our office today to give us an opportunity to examine the Claims Offices' ruling. We welcome the opportunity to help.